Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
BSGM

BSGM - BioSig Technologies Inc Stock Price, Fair Value and News

$3.25-0.21 (-6.07%)
Market Closed

4/100

BSGM

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

4/100

BSGM

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.65

Target 3M

$2.98

Target 6M

$2.81

BSGM Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BSGM Price Action

Last 7 days

-8.2%

Last 30 days

-3.0%

Last 90 days

-33.1%

Trailing 12 Months

200.9%

BSGM RSI Chart

BSGM Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BSGM Valuation

Market Cap

128.5M

Price/Earnings (Trailing)

-3.23

Price/Sales (Trailing)

3.9K

EV/EBITDA

-3.05

Price/Free Cashflow

-16.23

BSGM Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.65

Target 3M

$2.98

Target 6M

$2.81

BSGM Fundamentals

BSGM Revenue

Revenue (TTM)

40.0K

BSGM Earnings

Earnings (TTM)

-39.8M

Earnings Growth (Yr)

-714.21%

Earnings Growth (Qtr)

23.49%

BSGM Profitability

Operating Margin

-397.50%

EBT Margin

-101540.00%

Return on Equity

575.32%

Return on Assets

-30.53%

Free Cashflow Yield

-6.16%

BSGM Investor Care

Shares Dilution (1Y)

129.42%

Diluted EPS (TTM)

-1.35

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20250000
202429.0K40.0K39.0K40.0K
2023219.0K152.0K85.0K18.0K
2022402.3K363.5K324.8K286.0K
2021000441.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About BioSig Technologies Inc

BSGM
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
 CEO
 WEBSITEbiosig.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES47

BioSig Technologies Inc Frequently Asked Questions

BSGM is the stock ticker symbol of BioSig Technologies Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Jan 23 2026, market cap of BioSig Technologies Inc is 128.51 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check BSGM's fair value in chart for subscribers.

The fair value guage provides a quick view whether BSGM is over valued or under valued. Whether BioSig Technologies Inc is cheap or expensive depends on the assumptions which impact BioSig Technologies Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BSGM.

As of Fri Jan 23 2026, BSGM's PE ratio (Price to Earnings) is -3.23 and Price to Sales (PS) ratio is 3.92 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BSGM PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, BioSig Technologies Inc has provided -0.206 (multiply by 100 for percentage) rate of return.